Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact firstname.lastname@example.org.
SOURCE Panasas, Inc.
SUNNYVALE, Calif., June 23, 2014 /PRNewswire/ -- Panasas, Inc., the leader in hybrid scale-out NAS for technical research and enterprise customers, today announced that Genedata has chosen Panasas ActiveStor ® 14 to improve the performance of its RNA/DNA sequence data analysis.
Genedata develops and markets software solutions for the statistical analysis and scientific interpretation of extremely large biological datasets. They analyze data that requires immense throughput, such as typically found within the pharmaceutical, industrial, biotechnological and agro biotechnological worlds. Companies within those fields use Genedata's software systems in their R&D processes to identify causes of diseases, profile molecules for their mode of action, stratify patient populations or select the best strain for production or breeding.
"When analyzing RNA/DNA data, the typical bottleneck within the data processing pipeline is the IO bandwidth of the mapped short read from disk. A single patient sample may easily reach hundreds of gigabytes per sample and has to be passed through several times during statistical analysis," commented Dr. Marc Flesch, Product Manager, Genedata. "CPU bottlenecks are typically overcome by increasing the size of the compute nodes. However, IO bandwidth shortcomings in shared-disk software designs normally remain. We overcame this issue with the scale-out NAS solution from Panasas."
"We are delighted that Gendata has chosen Panasas to satisfy its high performance storage requirements," said Anthony Yeates, Vice President of EMEA Sales at Panasas. "ActiveStor's scalable hybrid architecture provides unmatched price performance for this type of application. In addition, it has proven to be very easy to maintain."
Supplying 19 of the top 20 pharmaceutical and 5 out of the top 6 agro-biotechnological companies, Genedata's software solution is well known for its scalability and high performance. Choosing Panasas ActiveStor® 14 ensures they can stay ahead of the curve by exploiting its flexible capacity upgrade allowing Genedata to react to new customer projects, helping save money and time.
For more information on Panasas solutions, visit panasas.com/products or meet Panasas at ISC'14, Booth 742.
Panasas ActiveStor® hybrid scale-out NAS appliances drive enterprise and research innovation by accelerating workflows and simplifying data management. ActiveStor solutions leverage the patented PanFS® storage operating system, delivering high performance and reliability at scale from an appliance that is as easy to manage as it is fast to deploy. Now in its fifth generation, ActiveStor is optimized for the most demanding big data workloads in energy, government, life sciences, manufacturing, media, and university environments and has been deployed in more than fifty countries worldwide. For more information, visit www.panasas.com.
Genedata transforms data into intelligence with a portfolio of advanced software solutions, which make research data accessible and understandable and research processes more efficient. These solutions are used worldwide by leading pharmaceutical, industrial, and agricultural biotechnology companies as well as academic research organizations. Genedata innovations enable scientific discovery that fights disease and improves health and quality of life worldwide. Founded in 1997, Genedata is headquartered in Switzerland, and has offices in Germany, Japan, and the US. www.genedata.com
Napier Partnership Ltd.
+44 (0) 1243 531123
©2014 Panasas, Inc. Panasas, the Panasas logo, ActiveStor, and PanFS are registered trademarks or trademarks of Panasas, Inc.
©2012 PR Newswire. All Rights Reserved.